The tissue distribution and excretion of [ 14C]2,3,7,8-tetrachlorodibenzofuran (TCDF) in adult male guinea pigs was studied up to 9 days following an iv or po administration (6.0 μg/kg, 0.02 μmol/kg). Greater than 90% of the dose was absorbed after po administration. Tissue concentrations and excreta were examined for [ 14C]TCDF-derived material for periods ranging from 1 hr to 9 days after administration. Liver, muscle, skin, and adipose tissue were found to be the most important tissues for the distribution of this compound. The highest levels of radioactivity were initially located in the liver and muscle, and then redistributed to the skin and adipose tissue. At 1 day the radioactivity began to be redistributed back to the liver; this second redistribution appeared to be due to the mobilization of fat stores associated with the overt toxicity of TCDF. At all time points, the specific activity of TCDF-derived radioactivity (percentage dose/g tissue) was highest in liver, fat, and adrenals, respectively. The initial phase for the elimination of radioactivity from the liver and muscle had a half-life of 3.9 and 15.7 hr, respectively. Excretion in the urine and feces each accounted for only 6.6 and 6.5% of the dose, respectively, during the 9 days following administration. Greater than 90% of the extracted radioactivity in feces and tissues examined cochromatographed with parent TCDF. However, the radioactivity in the urine did not chromatograph with TCDF and appeared to be a metabolite(s) more polar than TCDF. Studies of the accumulation and distribution of TCDF-derived material after six or more weekly doses of 1 μg/kg TCDF each demonstrated that TCDF is accumulated in liver, adipose tissue, and skin, and that when a body burden of approximately 5.6 to 6.6 μg/kg was attained, the toxicity of this compound was irreversible and resulted in progressive weight loss and death.